For informational purposes only — not investment advice

← Back to signals

CME

LONGINSIDER BUYINSIDER SELLCONGRESS BUY

CME GROUP INC

Research: Finviz ↗·Perplexity ↗

Funds
3
Score
3.54
vs SPY
+18.8%
Stock return (since Q-end)
+22.9%
SPY return (since Q-end)
+4.0%
Current price
$270.03
Days to cover (short int.)
3.3d↑+3.1%
as of 2026-09-15

News Summary

Positive

CME Group delivered Q2 2026 earnings and revenue beats with record trading volumes in June (30.6M ADV) and strong Q3 momentum (29.4M ADV, up 22% YoY), supported by a Wells Fargo 'strong-buy' upgrade in early October. However, the planned leadership transition (Duffy to Executive Chairman, Fitzpatrick to CEO effective March 2027) triggered a 4% stock decline on announcement, and broader analyst consensus remains cautious at 'Hold' despite the recent upgrade.

Red flags

  • •Leadership transition announced June 17, 2026 with 9-month runway to March 1, 2027 implementation creates near-term uncertainty
  • •Stock initially sold off 4% on CEO succession announcement, signaling investor concern about management change
  • •Withdrawal of planned 24/7 crude oil futures contract indicates product development setback and potential regulatory or market pushback

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Point72Steve Cohen744K+654K$164M0.3%+726%Existing
Baupost GroupSeth Klarman619K+619K$137M2.5%—NEW
Viking GlobalAndreas Halvorsen153K+153K$34M<0.1%—NEW

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where CME ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Baupost Group

position #14 of this fund's book

  1. 11TELEFLEX INCORPORATED$179M
  2. 12NORWEGIAN CRUISE LINE HLDGS$163M
  3. 13MOLINA HEALTHCARE INC$145M
  4. 14CME GROUP INC$137M
  5. 15HERBALIFE LTD$122M
  6. 16EAGLE MATLS INC$119M
  7. 17GDS HLDGS LTD$113M

Values are quarter-end position sizes. Shown only for funds where CME ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Insider Activity

NameTitleTypeSharesPriceValueFiledSrc
SHEPARD WILLIAM R—BUY292$268.76$0.08M2026-09-25↗
Cook Elizabeth A—SELL500$280.11$0.14M2026-09-14↗
DUFFY TERRENCE AChairman and CEOSELL14K$274.41$3.94M2026-09-10↗
DUFFY TERRENCE AChairman and CEOSELL628$275.03$0.17M2026-09-10↗

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
Vanguard Capital ManagementSC 13G27.0M7.5%2026-04-29↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan Armstrongsenate—BUY$1,001 - $15,0002026-03-272026-07-21↗

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.